Hormone substitution beginning when, with what, how long?
Breckwoldt, M.; Keck, C.
Geburtshilfe und Frauenheilkunde 54(5): M67-M69
1994
ISSN/ISBN: 0016-5751 PMID: 8050681 Document Number: 432175
Document emailed within 1 workday
Related Documents
Hamerlynck, J.V.; van Leeuwen, F.E. 1996: Long-term postmenopausal hormone substitution and incidence of breast cancer: the Nurses' Health Study Nederlands Tijdschrift Voor Geneeskunde 140(14): 759-761Wildemeersch, D. 2016: Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution - a review Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 32(8): 598-601
Keller, P.J.; Maurer-Major, E. 1997: Hormone substitution in menopause Praxis 86(38): 1458-1462
Delaloye, J.F. 1995: Hormone substitution following a gynecological cancer Revue Medicale de la Suisse Romande 115(5): 357-359
Hakimi, R. 2006: Hormone substitution--a questionable IGeL indication MMWFortschrittederMedizin 148(27-28): 16
De Boer, H.; van der Veen, E.A. 1996: Growth hormone deficiency and substitution in adults Nederlands Tijdschrift Voor Geneeskunde 140(28): 1441-1445
Lauritzen, C. 1990: Colorectal carcinoma and substitution hormone treatment in menopause Zentralblatt für Gynakologie 112(23): 1493-1494
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Boissonnas, A. 1994: How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections? Annales de Medecine Interne 145 Suppl. 3: 54-55
Kuhl, H. 1997: Current status: hormone substitution and risk of endometrial carcinoma Zentralblatt für Gynakologie 119(6): 296-297
Lippert, T.H.; Seeger, H.; Mueck, A.O. 1999: The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause Zentralblatt für Gynakologie 121(10): 467-472
Kattamis, C.A.; Kattamis, A.C. 1995: Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination Seminars in Hematology 32(4): 269-279
Jamin, C. 1995: Biological surveillance of hormone substitution: relying on the plasma levels of estradiol or the products used? Journal de Gynecologie Obstetrique et Biologie de la Reproduction 24(5): 467-474
Bocca, G.; van Beek, A.P.; de Bont, E.S.J.M. 2009: Grow hormone deficiency in children after radiation for a brain tumor. Quickly start with substitution Nederlands Tijdschrift Voor Geneeskunde 153(17): 792-793
Bocca, G.; van Beek, A.P.; de Bont, E.S.J.M. 2009: Grow hormone deficiency in children after radiation for a brain tumor. Quickly start with substitution Nederlands Tijdschrift Voor Geneeskunde 153(17): 792-793
Van der Mooren, M.J.; Merkus, J.M. 1996: Favorable effects of menopausal hormone substitution therapy on risk factors for ischemic heart disease Nederlands Tijdschrift Voor Geneeskunde 140(25): 1328-1329
Hayashizaki, Y.; Hiraoka, Y.; Endo, Y.; Miyai, K.; Matsubara, K. 1989: Thyroid-stimulating hormone (TSH) deficiency caused by a single base substitution in the CAGYC region of the beta-subunit EMBO Journal 8(8): 2291-2296
Valdés-Ferrer, S.I.án. 2014: The challenges of long-term sepsis survivors: when surviving is just the beginning Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 66(5): 439-449
Mo, Z.N.; Huang, X.; Zhang, S.C.; Yang, J.R. 1995: Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels Journal of Urology 154(6): 2065-2069
Gass, R.; Neff, M. 1995: Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate) Schweizerische Medizinische Wochenschrift 125(34): 1583-1591